Testosterone Treatment in Men With Chronic Kidney Disease

Part of paid clinical trials in St Louis, Missouri.

Sponsor
St. Louis University
Study ID
NCT05249634
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Hypogonadism, Male
  • Kidney Disease, Chronic

Eligibility Criteria

Sex
MALE
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Jatenzo Pill — DRUG
    oral tablet daily

Study Details

This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).

Key Dates

Start date
Mar 15, 2022
Status verified
Apr 2026
Primary completion
Jun 30, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: treatment
    JATENZO daily for 6 months

Primary Outcome Measure

Testosterone concentrations [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Saint Louis UniveristySt LouisMissouri63104
Jennifer Newman

Find similar trials in St Louis, MO

By research site
Saint Louis Univeristy· St Louis, MO

Related Studies